Pharma Mar (WBO:PHM) Dividend Payout Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:PHM Pharma Mar SA WBO:PHM
67 GF Score
Price €74.20
GF Value €85.35
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Pharma Mar Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Pharma Mar's Dividend Payout Ratio for the months ended in Jun. 2026 was .

The historical rank and industry rank for Pharma Mar's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Pharma Mar was 13.54. The lowest was 0.06. And the median was 0.21.

WBO:PHM's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.4
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-09-22), the Dividend Yield % of Pharma Mar is 1.36%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Pharma Mar was 4.32%. The lowest was 0.36%. And the median was 0.98%.

Pharma Mar's Dividends per Share for the months ended in Jun. 2026 was €.

During the past 12 months, Pharma Mar's average Dividends Per Share Growth Rate was -100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 8.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Pharma Mar was 10.60% per year. The lowest was 2.70% per year. And the median was 7.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Pharma Mar (WBO:PHM) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Pharma Mar Dividend Payout Ratio Related Terms

Pharma Mar Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Dividend Payout Ratio Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.19 12.29 0.54 0.19

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 - 0.24 - -

WBO:PHM vs VRTX, REGN, MRNA: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Pharma Mar's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Dividend Payout Ratio falls into.


WBO:PHM
67GF Score
Pharma Mar SA WBO:PHM
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Pharma Mar's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.81/ 4.2492465478714
=0.19

Pharma Mar's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=/ -0.056068297185049
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Pharma Mar (WBO:PHM) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of €74.20 is trading 13.1% below its estimated GF Value™ of €85.35. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for WBO:PHM:

  • Dividend Payout Ratio:
  • GF Value™: €85.35 vs. price of €74.20 (13.1% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the WBO:PHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is a Spanish biopharmaceutical company focused on the research, development, and commercialization of anticancer drugs derived from marine organisms. Its oncology portfolio includes Yondelis (trabectedin), approved for soft tissue sarcoma and ovarian cancer, and Aplidin (plitidepsin), along with a pipeline of compounds such as lurbinectedin (Zepsyre). The company sells its products through subsidiaries and partnerships with pharmaceutical companies in Europe, the United States, and other international markets. Pharma Mar also operates a consumer chemicals division that produces and markets household insecticides, air fresheners, wood treatment products, and paints. The oncology segment generates the majority of revenue through product sales and licensing and collaboration agreements, while the consumer chemicals business provides an additional, more stable revenue stream. Pharma Mar is headquartered in Madrid, Spain, and its shares trade on the Spanish stock exchange.
67GF Score

Get the complete analysis for WBO:PHM

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.20
Price
€85.35
GF Value